If someone had a recent TST, they should still receive the COVID-19 vaccine. The only concern is if the TST is placed in proximity to where the COVID-19 vaccine was administered because the person reading the TST may not be able to clearly determine a positive TST versus the vaccine local reaction. Therefore, the TST [...]
Given the lack of data on the safety and efficacy of mRNA COVID-19 vaccines administered simultaneously with other vaccines, the vaccine series should routinely be administered alone, with a minimum interval of 14 days before or after administration with any other vaccine. However, mRNA COVID-19 and other vaccines may be administered within a shorter period [...]
No. The COVID-19 will be the only vaccine offered during the clinic dates.
The process for documenting verbal approval is noted in section 3 of the COVID-19 vaccine consent form.
We will be providing the consent form in English, Spanish, and Korean. We will distribute the alternative language consent forms upon request.
Facilities can send consent forms in bulk or individually. We will enter information on our end as they come our way.
As part of the vaccine provider agreement, upon administration of a COVID-19 vaccine dose, the pharmacy is required to submit certain information directly to state and federal agencies. Our consent and screening form is designed to capture the necessary information and thus the facility must utilize and submit the pharmacy-provided consent form. With that being [...]
Consent forms will be made available prior to the clinic date through the PS portal. Consent forms will not be accepted during scheduled clinics.
This will be handed on a resident-by-resident basis. We will do our best to leverage our network to take care of all residents.
For Phase 2, we anticipate being able to receive COVID-19 vaccines as soon as March 1, 2021. When we receive more information we will reach out to schedule your vaccine clinic dates.